Hematology | Oncology


Medical Oncology
We offer evaluations, treatment and follow-up care for a broad range of cancers by several specialists all in one place, on the same day. Our participation in national clinical trials involving a variety of cancers offers patients promising new treatments for all stages of their disease. We have specific multidisciplinary programs for the diagnosis and treatment of lung cancer, breast cancer, cancers of the head and neck, gastrointestinal cancers and skin cancers.

Hematology
We offer consultation and treatment for a broad range of benign and malignant conditions, such as hemoglobinopathies (sickle cell anemia and thalassemia), hemochromatosis, bleeding and thrombotic disorders (von Willebrand's disease and hemophilia), hypercoagulable states, myeloproliferative disorders, myelodysplasia and anemia, and malignancies such as leukemia, lymphoma and myeloma. We work closely with the staff of the Transfusion Medicine Service/Blood Bank and have developed innovative techniques for harvesting, storing and re-infusing blood and its components, most notably for autologous peripheral blood stem cell infusion. Apheresis is also available for treatment of a variety of disorders including sickle cell disease, Waldenstrom's macroglobulinemia and cryoglobulinemia.

Autologous Stem Cell Transplantation
We employ autologous peripheral blood stem cell infusion as an alternative to traditional bone marrow transplantation. The procedure has several advantages including it can be done on an outpatient basis or during a short inpatient stay, and it has a lower risk of infection or bleeding.

Amyloidosis
Boston Medical Center is an international referral center for the diagnosis and treatment of amyloidosis, a rare group of diseases caused by the abnormal accumulation of the protein amyloid in various parts of the body. Although amyloidosis is not cancer, treatments for it are very similar. We have been successful in using chemotherapy with stem cell transplantation to rid the body of the excess protein and minimize the damage the disease causes to other organs.

Skin Cancer Practice
We conduct a multidisciplinary practice focusing on cancers involving the skin, especially malignant melanoma and cutaneous T cell lymphoma. Our oncologists, dermatologists, and surgeons work together to offer aggressive treatment for such tumors including biologic therapies with vaccines and interferon. Our dermatologists also treat the less invasive types of skin cancers such as basal and squamous cell carcincomas. Mohs micrographic surgery, developed at Boston Medical Center, is an innovative technique used to remove these tumors.